INSIDER/TRADES Sign in Get started

Slagel Dean

Insider CIK 1597359 · CARA Director

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
CARA Cara Therapeutics, Inc.	S Sale	2017-06-29	2017-07-03	20,862	$26.58	$554.5K	1,064,338	SEC↗
CARA Cara Therapeutics, Inc.	S Sale	2017-06-29	2017-07-03	229,138	$25.81	$5.91M	1,085,200	SEC↗
CARA Cara Therapeutics, Inc.	A Award deriv	2017-06-21	2017-06-23	15,000	—	$0	15,000	SEC↗
CARA Cara Therapeutics, Inc.	A Award deriv	2016-06-15	2016-06-17	15,000	—	$0	15,000	SEC↗
CARA Cara Therapeutics, Inc.	S Sale	2016-01-05	2016-01-05	31,224	$17.01	$531.1K	1,314,338	SEC↗
CARA Cara Therapeutics, Inc.	S Sale	2016-01-05	2016-01-12	31,224	$17.01	$531.1K	1,314,338	SEC↗
CARA Cara Therapeutics, Inc.	S Sale	2015-12-31	2016-01-05	12,776	$17.00	$217.2K	1,345,562	SEC↗
CARA Cara Therapeutics, Inc.	S Sale	2015-12-31	2016-01-12	12,776	$17.00	$217.2K	1,345,562	SEC↗
CARA Cara Therapeutics, Inc.	A Award deriv	2015-06-08	2015-06-10	13,500	—	$0	13,500	SEC↗
CARA Cara Therapeutics, Inc.	S Sale	2015-05-19	2015-05-19	32,266	$10.00	$322.7K	1,358,338	SEC↗
CARA Cara Therapeutics, Inc.	S Sale	2015-05-18	2015-05-19	82,945	$10.04	$832.8K	1,390,604	SEC↗
CARA Cara Therapeutics, Inc.	S Sale	2015-05-15	2015-05-19	73,600	$10.00	$736.0K	1,473,549	SEC↗
CARA Cara Therapeutics, Inc.	C Conversion deriv	2014-02-05	2014-02-05	210,373	—	$0	0	SEC↗
CARA Cara Therapeutics, Inc.	C Conversion deriv	2014-02-05	2014-02-05	200,000	—	$0	0	SEC↗
CARA Cara Therapeutics, Inc.	C Conversion	2014-02-05	2014-02-05	84,149	—	$0	1,547,149	SEC↗
CARA Cara Therapeutics, Inc.	C Conversion	2014-02-05	2014-02-05	80,000	—	$0	1,463,000	SEC↗
CARA Cara Therapeutics, Inc.	A Award deriv	2014-01-30	2014-01-31	20,000	—	$0	20,000	SEC↗